MINNEAPOLIS, MN--(eMediaWorld - February 4, 2010) - Protectus Medical Devices, Inc. ("Protectus Medical Devices") (OTCBB: PTMD), a developer and marketer of innovative medical devices, announced today that the Company has filed a patent for its "Living Hinge," a critical component in the functioning of the Company's Safety Dental Syringe, Safety IV Catheter and Safety Phlebotomy devices. The innovative Protectus Safety Syringe is designed to significantly reduce or eliminate accidental needlestick injuries that have plagued the healthcare workplace for decades.

"The Living Hinge is a significant addition to Protectus Medical Device's Intellectual Property portfolio," said Dr. John Salstrom, President and CEO of Protectus Medical Devices, Inc. "The Living Hinge's unique, innovative design by Jack Dillard, COO, has two opposing teeth that are spring-biased and clamp over a lip that holds the protective sliding sheath back to expose the needle during use, but which retracts automatically immediately after use. This patent, when issued, will afford the Company an additional layer of protection for our Safety Dental Syringe, Safety IV Catheter and Safety Phlebotomy Devices. We intend to continue to add value to the Company with additional patents in the near future."

The Protectus Safety Syringe is the only fully automatic, self-sheathing safety hypodermic syringe that currently meets all U.S. Federal Government and OSHA mandates designed to protect both healthcare workers and patients alike. It is designed to significantly reduce or eliminate accidental needlestick injuries that have plagued the healthcare workplace for decades. More information about Protectus Medical Devices may be found at the Company's corporate website at www.protectusmedical.com.

About Protectus Medical Devices, Inc. (formerly, E-18 Corp.)

Protectus Medical Devices, Inc. (OTCBB: PTMD) (formerly, E-18 Corp.), through its wholly owned subsidiary, SquareOne Medical, Inc., develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim. Protectus Medical Devices has successfully patented its automatic, self-sheathing hypodermic safety syringe product, and, based on the results of full comparison clinical trials, the Protectus Safety Syringe (formerly the SquareOne Safety Syringe) has received the required 510(k) permission from the U.S. FDA to manufacture and market the device in the U.S. More information about the Company may be found at www.protectusmedical.com.

Forward-Looking Statements

This release contains "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. These forward-looking statements are subject to various risks and uncertainties that could cause the business and financial results of Protectus Medical Devices, Inc. to differ materially from those currently anticipated, including the risk factors identified in Protectus Medical Devices, Inc.'s filings with the Securities and Exchange Commission.

Major Wire Distributions  Starting at only $45 and Complete OTCBB Distribution only $249